Rusch VW - Memorial Sloan-Kettering Cancer Center
Mesothelioma Cancer Expert at Memorial Sloan-Kettering Cancer Center, New York, NY
Mesothelioma Cancer Expert - Rusch VW - Current Listing of Published Papers
The following is a listing of research papers by Rusch VW in the field of mesothelioma cancer.
| Rusch VW. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care? J Clin Oncol. 2003 Jul 15;21(14):2629-30. Pubmed 12860935 No address listed. |
| Rusch VW. Indications for pneumonectomy. Extrapleural pneumonectomy. Chest Surg Clin N Am. 1999 May;9(2):327-38, x. Pubmed 10365266 Thoracic Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. [mskcc.org] |
| Rusch VW. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 1997 Oct;9(4):367-72. Pubmed 9352954 Memorial Sloan-Kettering Cancer Center, Department of Surgery and Cornell University Medical College, New York, NY 10021, USA. |
| Rosenzweig KE, Fox JL, Zelefsky MJ, Raben A, Harrison LB, Rusch VW. A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma. Brachytherapy. 2005;4(1):30-3. Pubmed 15737904 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. [mskcc.org] |
| Illei PB, Ladanyi M, Rusch VW, Zakowski MF. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 2003 Feb 25;99(1):51-6. Pubmed 12589646 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. |
| Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains MS, Downey RJ, Ginsberg RJ. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2001 Oct;122(4):788-95. Pubmed 11581615 Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. [mskcc.org] |
| Gupta V, Mychalczak B, Krug L, Flores R, Bains M, Rusch VW, Rosenzweig KE. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1045-52. Epub 2005 Jul 28. Pubmed 16054774 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. |
| Yajnik S, Rosenzweig KE, Mychalczak B, Krug L, Flores R, Hong L, Rusch VW. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1319-26. Pubmed 12873676 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. |
| Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2003 Jul;126(1):11-6. Pubmed 12878934 Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. [mskcc.org] |
| Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res. 2003 Jun;9(6):2108-13. Pubmed 12796375 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, USA. |
| Khokhar NZ, Lam AF, Rusch VW, Sirotnak FM. Despite some expression of folate receptor alpha in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated. J Thorac Cardiovasc Surg. 2002 May;123(5):862-8. Pubmed 12019370 Program of Molecular Pharmacology and Experimental Therapeutics and Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. |
| Khokhar NZ, She Y, Rusch VW, Sirotnak FM. Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums. Clin Cancer Res. 2001 Oct;7(10):3199-205. Pubmed 11595715 Program in Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. |
| Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999 Nov;68(5):1799-804. Pubmed 10585061 Department of Surgery, and Biostatistics Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. [mskcc.org] |
| Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol. 1999 Apr;172(4):1039-47. Pubmed 10587144 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. |
